BG101125A - Low molecular biologically active substance of yeasts and method for its preparation - Google Patents
Low molecular biologically active substance of yeasts and method for its preparationInfo
- Publication number
- BG101125A BG101125A BG101125A BG10112597A BG101125A BG 101125 A BG101125 A BG 101125A BG 101125 A BG101125 A BG 101125A BG 10112597 A BG10112597 A BG 10112597A BG 101125 A BG101125 A BG 101125A
- Authority
- BG
- Bulgaria
- Prior art keywords
- yeasts
- low molecular
- preparation
- active substance
- biologically active
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
- C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
- C07K14/395—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Saccharomyces
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/06—Anabolic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/911—Microorganisms using fungi
- Y10S435/94—Saccharomyces
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/911—Microorganisms using fungi
- Y10S435/94—Saccharomyces
- Y10S435/942—Saccharomyces cerevisiae
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Physical Education & Sports Medicine (AREA)
- Toxicology (AREA)
- Neurology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19517020A DE19517020A1 (de) | 1995-05-10 | 1995-05-10 | Niedermolekularer Wirkstoffextrakt aus Hefen und Verfahren zu seiner Herstellung |
PCT/EP1996/001886 WO1996035439A1 (de) | 1995-05-10 | 1996-05-07 | Niedermolekularer wirkstoffextrakt aus hefen und verfahren zu seiner herstellung |
Publications (1)
Publication Number | Publication Date |
---|---|
BG101125A true BG101125A (en) | 1998-02-27 |
Family
ID=7761481
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG101125A BG101125A (en) | 1995-05-10 | 1997-01-10 | Low molecular biologically active substance of yeasts and method for its preparation |
Country Status (11)
Country | Link |
---|---|
US (2) | US6143295A (xx) |
EP (1) | EP0777489B1 (xx) |
JP (1) | JP3031720B2 (xx) |
AT (1) | ATE203673T1 (xx) |
BG (1) | BG101125A (xx) |
CZ (1) | CZ288826B6 (xx) |
DE (1) | DE59607409D1 (xx) |
HU (1) | HUP9700074A3 (xx) |
PL (1) | PL318139A1 (xx) |
RU (1) | RU2148636C1 (xx) |
WO (1) | WO1996035439A1 (xx) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2018423B1 (en) * | 2006-05-10 | 2020-02-12 | Novozymes A/S | Method for extracting components from a yeast cell culture |
CN101513248B (zh) * | 2008-02-19 | 2013-05-15 | 安琪酵母股份有限公司 | 含有肌苷酸二钠盐和鸟苷酸二钠盐的酵母抽提物及其制备方法 |
CN101513246B (zh) * | 2008-02-21 | 2012-12-05 | 安琪酵母股份有限公司 | 一种酵母抽提物、制备方法及其应用 |
JP5688687B2 (ja) | 2009-04-01 | 2015-03-25 | 味の素株式会社 | ペプチドのコク味付与用途 |
WO2011129462A2 (en) | 2010-04-12 | 2011-10-20 | Ajinomoto Co., Inc. | A YEAST EXTRACT CONTAINING γ-Glu-X OR γ-Glu-X-Gly AND A METHOD FOR PRODUCING THE SAME |
RU2496864C2 (ru) * | 2010-07-05 | 2013-10-27 | Закрытое акционерное общество "Научно-исследовательский институт "Аджиномото-Генетика" (ЗАО АГРИ) | ДРОЖЖЕВОЙ ЭКСТРАКТ, СОДЕРЖАЩИЙ ГАММА-Glu-X ИЛИ ГАММА-Glu-X-Gly, И СПОСОБ ЕГО ПОЛУЧЕНИЯ |
EP3744853A1 (en) * | 2019-05-29 | 2020-12-02 | Ohly GmbH | Trehalose-rich yeast hydrolysate |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5328984B2 (xx) * | 1973-11-09 | 1978-08-17 | ||
CH651063A5 (de) * | 1981-05-14 | 1985-08-30 | Elkawi Ag | Verfahren zur gewinnung anaboler, atmungsfoerdernder, niedermolekularer wirkstoffe fuer prophylaktische, therapeutische, zell- und gewebekulturtechnische zwecke. |
US4409246A (en) * | 1981-07-22 | 1983-10-11 | Labatt Brewing Company Limited | Yeast strain for fermenting high plato value worts |
US4797359A (en) * | 1983-05-10 | 1989-01-10 | Board Of Regents, The University Of Texas System | Heat shock regulated production of selected and fused proteins in yeast |
GB2175804A (en) * | 1985-05-29 | 1986-12-10 | Dr Douglas Nelson | Treating cramp |
DE3711054A1 (de) * | 1987-04-02 | 1988-10-13 | Socop Nahrungsmittel | Biophysikalisch derivatisiertes hefepraeparat, verfahren zu dessen herstellung und dieses hefepraeparat enthaltende futtermittel und pflanzenwuchsstoffe |
US6013485A (en) * | 1996-05-07 | 2000-01-11 | Thymopharma, Ag | Low-molecular weight active ingredient extract from yeasts and method for producing it |
-
1996
- 1996-05-07 RU RU97102102A patent/RU2148636C1/ru active
- 1996-05-07 PL PL96318139A patent/PL318139A1/xx unknown
- 1996-05-07 EP EP96919682A patent/EP0777489B1/de not_active Expired - Lifetime
- 1996-05-07 WO PCT/EP1996/001886 patent/WO1996035439A1/de active IP Right Grant
- 1996-05-07 AT AT96919682T patent/ATE203673T1/de not_active IP Right Cessation
- 1996-05-07 DE DE59607409T patent/DE59607409D1/de not_active Expired - Fee Related
- 1996-05-07 JP JP8533733A patent/JP3031720B2/ja not_active Expired - Lifetime
- 1996-05-07 CZ CZ199767A patent/CZ288826B6/cs not_active IP Right Cessation
- 1996-05-07 HU HU9700074A patent/HUP9700074A3/hu unknown
- 1996-12-18 US US08/768,622 patent/US6143295A/en not_active Expired - Fee Related
-
1997
- 1997-01-10 BG BG101125A patent/BG101125A/xx unknown
-
2000
- 2000-08-24 US US09/644,565 patent/US6348335B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CZ6797A3 (en) | 1997-06-11 |
ATE203673T1 (de) | 2001-08-15 |
HUP9700074A3 (en) | 2001-02-28 |
JPH10505612A (ja) | 1998-06-02 |
US6348335B1 (en) | 2002-02-19 |
RU2148636C1 (ru) | 2000-05-10 |
WO1996035439A1 (de) | 1996-11-14 |
US6143295A (en) | 2000-11-07 |
JP3031720B2 (ja) | 2000-04-10 |
HUP9700074A2 (en) | 1997-06-30 |
DE59607409D1 (de) | 2001-09-06 |
EP0777489B1 (de) | 2001-08-01 |
CZ288826B6 (cs) | 2001-09-12 |
EP0777489A1 (de) | 1997-06-11 |
PL318139A1 (en) | 1997-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9705954A (es) | Formulaciones y metodos para reducir irritacion de la piel. | |
ATE281840T1 (de) | Behandlung von diarrhoe | |
EP0254032A3 (en) | Neutral metalloendopeptidase inhibitors in the treatment of hypertension | |
IL121790A0 (en) | Method for preventing and treating sensorineural hearing loss and vestibular disorders using glial cell line-derived neurotrophic factor (GDNF) protein product | |
MX9710479A (es) | Extracto de iridaceas y composiciones que la contienen. | |
CA2250078A1 (en) | Processes for the replication of influenza viruses in cell culture, and the influenza viruses obtainable by the process | |
MD1638F2 (en) | Quinazolines, process for obtaining thereof, pharmaceutical composition and therapeutic method of growth inhibition and proliferation of the higher organisms and microorganisms cells | |
ATE210965T1 (de) | Zusammensetzungen zur topischen abgabe von aktiven wirkstoffen | |
DE59410052D1 (de) | Verwendung von nona- und dekapeptiden zur herstellung eines arzneimittels zur bekämpfung von aids | |
WO1996028022A3 (en) | Fatty acid based compositions and methods for the control of plant infections and pests | |
AU3902299A (en) | Methods of treating microbial infection and therapeutic formulations therefor | |
UA35611C2 (uk) | Композиція місцевого застосування для інгібування росту волос у ссавців, спосіб із її використанням та композиція місцевого застосування для доставки водорозчинного фармакологічного засобу до шкіри | |
BG101125A (en) | Low molecular biologically active substance of yeasts and method for its preparation | |
AU1384995A (en) | Human circulating cytokine cc-1 | |
CA2131565A1 (en) | Organopolysiloxanes Containing Hydrophilic Groups | |
ATE263239T1 (de) | Produkte des keratinocyten-wachstumsfaktors 2 (kgf-2) | |
DE60026883D1 (de) | Methoden und zusammensetzungen zur behandlung von schmerzen | |
CA2306595A1 (en) | Method for retaining or enriching y-aminobutylic acid in grass green leaves | |
AU1829195A (en) | Energy formulation | |
DK1012225T3 (da) | Fremgangsmåde og sammensætninger til formindskelse af ödelæggelse af öl | |
WO2001083722A3 (en) | Enzymes useful for treating and methods for treating mps-vi and cells lines for producing such enzymes recombinantly | |
CA2213575A1 (en) | Alkali metal formononetin and method of mycorrhizal stimulation | |
NZ333412A (en) | Plant proteins treated to reduce isoflavones, manganese and nucleotides and nutritional products made therefrom | |
GEP20022840B (en) | Form VI 5,6-Dichloro-2-(Isopropylamino)-1-(Beta-L-Ribofuranosyl-1H-Benzimidazole), Method for Their Production, Composition for Treating Virus Infections and Methods for Treatment | |
AU3610295A (en) | Fungus gliocladium catenulatum for biological control of plant diseases |